Understanding Neural Development--Use of Mouse Mutations

了解神经发育——利用小鼠突变

基本信息

项目摘要

Epilepsy Models and Calcium Channel Function P/Q-type voltage-dependent calcium channel CACNA1A mutations cause dominantly inherited migraine, episodic ataxia, and cerebellar atrophy in humans and cause recessively inherited ataxia, episodic dyskinesia, cerebellar atrophy, and absence epilepsy in mice. The basis of these species differences and the disease mechanism(s) are not understood. To address this question and to identify required P/Q function in vivo, we created a germline Cacna1a null mutation (designated Cacna1aFcrtm1) by gene targeting. Null mice develop dystonia and late-onset cerebellar degeneration in a specific pattern. This indicates a requirement for P/Q function for survival in a subset of cerebellar neurons. Homozygous null mice completely lack P/Q-type channel activity, and they also lack w-CTx-MVIIC receptors, indicating that a single gene encodes P/Q channel activity. An increase of L- and N-type current densities is detected in P/Q-null granule cells. Heterozygous Cacna1aFcrtm1/+ mice are phenotypically normal, despite having a 50% reduction in current density, indicating that reduced current density is not itself sufficient to cause the pathophysiology of spontaneous mouse mutants with ataxia and seizures. It has been hypothesized that R-type Ca currents result from the expression of the Cacna1e gene. To test this hypothesis, we examined the properties of voltage-dependent Ca channels in mice in which the Cacna1e channel subunit had been deleted. Application of omega-conotoxin GVIA, omega-agatoxin IVA, and nimodipine to cultured cerebellar granule neurons from wild-type mice inhibited components of the whole-cell Ba current, leaving a "residual" R current with an amplitude of approximately 30% of the total Ba current. A minor portion of this R current was inhibited by the Cacna1e-selective toxin SNX-482, indicating that it resulted from the expression of Cacna1e. However, the majority of the R current was not inhibited by SNX-482. The SNX-482-sensitive portion of the granule cell R current was absent from Cacna1e knockout mice. We also identified a subpopulation of dorsal root ganglion (DRG) neurons from wild-type mice that expressed an SNX-482-sensitive component of the R current. However, as with granule cells, most of the DRG R current was not blocked by SNX-482. We conclude from these experiments that there exists a component of the R current that results from the expression of the Cacna1e Ca channel subunit but that the majority of R currents must result from the expression of other Ca channel alpha subunits. Deafness Models Mutations at the waltzer (v) locus result in deafness and vestibular dysfunction due to degeneration of the neuroepithelium within the inner ear. We showed that waltzer encodes a novel cadherin (Cdh23), which is most closely related to the Drosophila fat protein. A single nucleotide deletion in the vJ allele and a single nucleotide insertion in the v allele are predicted to truncate each protein near the N-terminus and produce a functional null allele. In situ hybridization analysis showed that Cdh23 is expressed in the sensory hair cells of the inner ear, where it has been suggested to be a molecule critical for crosslinking of the stereocilia. In addition, Cdh23 is expressed in the utriculo-saccular foramen, the ductus reuniens, and Reissner's membrane, suggesting that Cdh23 may also be involved in maintaining the ionic composition of the endolymph. Finally, mutations in human CDH23 have recently been described for two loci, DFNB12 and USH1D, which cause nonsyndromic deafness, identifying waltzer as a mouse model for human hearing loss. Neural Degeneration Models Mice homozygous for the ataxia (axJ) mutation develop severe tremors by 2-3 weeks of age, followed by hind limb paralysis and death by 6 weeks of age. Recently, we have shown that axJ encodes ubiquitin-specific protease 14 (Usp14). USPs comprise a large family of cysteine proteases that specifically cleave ubiquitin conjugates. Although Usp14 can cleave a ubiquitin-tagged protein, it is unable to process polyubiquitin, which is believed to be associated with the protein aggregates in Parkinson's disease (PD), spinocerebellar ataxia type 1 (SCA1), and gracile axonal dystrophy (GAD). The physiological substrate of Usp14 may therefore contain a short ubiquitin side chain, the removal of which may regulate processes such as protein localization and protein activity. Expression of Usp14 is significantly altered in axJ mice due to the insertion of an intracisternal-A particle (IAP) into intron 5 of Usp14. In situ hybridization studies show that Usp14 is expressed in a variety of neurons within the adult central nervous system (CNS), including the cerebral cortex, hippocampus, Purkinje cells, and deep cerebellar nuclei. However, unlike neurodegenerative disorders such as PD and SCA1 in humans or GAD in mice, there are no detectable ubiquitinated-protein aggregates nor is there neuronal cell loss in the axJ CNS. Instead, we identify synaptic connection defects in the axJ CNS, suggesting that USPs may be important factors in regulating the activity of synapses, possibly through neurotransmitter release.
癫痫模型与钙通道功能

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NANCY JENKINS COPELAND其他文献

NANCY JENKINS COPELAND的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NANCY JENKINS COPELAND', 18)}}的其他基金

Genetic Study of Pigment Granule Transport in the Mouse
小鼠色素颗粒运输的遗传学研究
  • 批准号:
    6559259
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Of Mice and Men: Using Mutations to Characterize Disease
小鼠和人类:利用突变来表征疾病
  • 批准号:
    7291859
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
UNDERSTANDING NEURAL DEVELOPMENT THROUGH MUTATIONS
通过突变了解神经发育
  • 批准号:
    6423820
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MOLECULAR GENETICS OF BHLH-ZIP TRANSCRIPTION FACTORS
BHLH-ZIP 转录因子的分子遗传学
  • 批准号:
    6423819
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Molecular Genetics--Mitf-Tfe Family of bHLH-Zip
分子遗传学--bHLH-Zip的Mitf-Tfe家族
  • 批准号:
    6559260
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Of Mice and Men: Using Mutations to Characterize Disease
小鼠和人类:利用突变来表征疾病
  • 批准号:
    6952171
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
A Genetic Approach to the Study of Vesicle Transport in
研究囊泡转运的遗传学方法
  • 批准号:
    7053838
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
A Genetic Approach to the Study of Vesicle Transport in
研究囊泡转运的遗传学方法
  • 批准号:
    7291780
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
GENETIC APPROACH STUDY OF PIGMENT GRANULE TRANSPORT
颜料颗粒运输的基因方法研究
  • 批准号:
    6423812
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
A Genetic Approach to the Study of Vesicle Transport
研究囊泡运输的遗传学方法
  • 批准号:
    6951681
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

L-type Calcium Channel SNP rs1006737: characterizing the genetic risks in MUD (Methamphetamine Use Disorder)
L 型钙通道 SNP rs1006737:表征 MUD(甲基苯丙胺使用障碍)的遗传风险
  • 批准号:
    10668210
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of a Novel Calcium Channel Therapeutic for the Treatment of Asthma
开发治疗哮喘的新型钙通道疗法
  • 批准号:
    10603554
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of a Novel Calcium Channel Therapeutic for Opioid Use Disorder
开发一种治疗阿片类药物使用障碍的新型钙通道疗法
  • 批准号:
    10684558
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Development of a Novel Medication for Alcohol Use Disorder with an Active IND Dual Inhibitor of T-Type Calcium Channel and Soluble Epoxide Hydrolase
使用 T 型钙通道和可溶性环氧化物水解酶的活性 IND 双重抑制剂开发治疗酒精使用障碍的新型药物
  • 批准号:
    10815882
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Novel Tools to Probe Trafficking and Function of Calcium Channel Signaling Complexes in Heart
探测心脏钙通道信号复合物的运输和功能的新工具
  • 批准号:
    10628914
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Mechanisms of L-type Calcium Channel Regulation in Heart Health and Disease
L 型钙通道在心脏健康和疾病中的调节机制
  • 批准号:
    10734121
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Structure-Function of Calcium Channel Complexes in Cardiac Physiology and Disease
钙通道复合物在心脏生理和疾病中的结构-功能
  • 批准号:
    10628911
  • 财政年份:
    2023
  • 资助金额:
    --
  • 项目类别:
Research Initiation Award: Defining the role of DJ-1 in regulating L-type voltage-dependent calcium channel expression in neuronal plasticity
研究启动奖:定义 DJ-1 在调节神经元可塑性中 L 型电压依赖性钙通道表达中的作用
  • 批准号:
    2200474
  • 财政年份:
    2022
  • 资助金额:
    --
  • 项目类别:
    Standard Grant
Design and Preclinical Development of First-in-Class Selective T-type Calcium Channel Blockers for Chronic Pain
用于治疗慢性疼痛的一流选择性 T 型钙通道阻滞剂的设计和临床前开发
  • 批准号:
    452107
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
    Operating Grants
Preventing the Calcium Channel Blocker – Lower Extremity Edema – Loop Diuretic Prescribing Cascade in Older Adults
预防钙通道阻滞剂 – 下肢水肿 – 老年人袢利尿剂处方级联
  • 批准号:
    10399417
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了